Background Lung cancer is the leading cause of cancer-related death worldwide, with non-
small cell lung cancer (NSCLC) accounting for most cases. While radiotherapy has …

Recent immunotherapy advances have convincingly demonstrated complete tumour
removal with long-term survival. These impressive clinical responses have rekindled …

Purpose We show the result of a randomized phase II clinical trial with an epidermal growth
factor (EGF)-based cancer vaccine in advanced non–small-cell lung cancer (NSCLC) …

Background The clinical state of oligometastases describes metastases limited in number
and extent, amenable to metastasis-directed therapy. We sought to analyze long-term …

Cytokine-induced killer (CIK) cells show cytolytic activity against tumor. The purpose of this
study was to evaluate the antitumor effect of dendritic cell (DC)-activated CIK cells in vitro …

Background aims Cytokine-induced killer (CIK) cells have shown cytolytic activity against
several tumor cells in vitro and in animal tumor models. Furthermore, CIK cells activated by …

Systematic collection of phenotypes and their correlation with molecular data has been
proposed as a useful method to advance in the study of disease. Although some databases …

Background Non-small cell lung cancer (NSCLC) represents 85% of all lung cancers. It is
estimated that 60% of patients with NSCLC at time of diagnosis have advanced disease …

Cytokine-induced killer (CIK) cells have the ability to kill tumor cells in vitro and in vivo. This
study aimed to evaluate the clinical effect of adjuvant immunotherapy with CIK cells on the …

Malignant ascites (MA) is a pathological condition due to a variety of primary abdominal and
extra-abdominal neoplasms. It is a primary cause of morbidity and presents many difficulties …